Penn Medicine Provider
Pathology and Laboratory Medicine
Zubair W. Baloch, MD, PhD
Accepting new patients
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP

About me

  • Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Sindh Medical College
  • Residency: Hahnemann University Hospital
  • Fellowship: Memorial Sloan-Kettering Cancer Center
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Baloch is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Xu B, Viswanathan K, Barbesier M, Ladenheim A, Antonescu CR, Ghossein R, Lubin D, Magliocca K, Matar S, Mikula MW, Resta IT, Roy D, Sohn SY, Verma A, Prasad ML, Rooper L, Brandwein-Weber M, Baloch Z, Katabi N. Hyalinizing Clear Cell Carcinoma (HCCC) of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading scheme , Mod Pathol: 2025


Hu AC, Passman JE, Baloch Z, Wachtel H. Adrenalectomy Leading to Early Diagnosis of ALECT2 Amyloidosis , Sage Open Pathol, 18: 2025,30502098251331780


Nachum S, Tondi Resta I, Baloch Z, Mandel SJ. Thyroid Nodules with Indeterminate Cytology and Negative Molecular Profile: Prevalence of Malignancy and Practice Paradigms for Surveillance , Thyroid, 35(3): 2025,265-273


Jin, Xueting, Koga, Shunsuke, Zhou, Xiao, Khan, Niaz, Baloch, Zubair Clinicopathologic characteristics of papillary thyroid carcinoma, tall cell subtype and subtype with tall cell features, an institutional experience (accepted for publication). , Hum Pathol: 2025


Rossi ED, Agarwal S, Erkilic S, Hang JF, Jalaly JB, Khanafshar E, Ladenheim A, Baloch Z. Psammoma bodies in thyroid: are they always indicative of malignancy? A multi-institutional study , Virchows Arch, 485(5): 2024,853-858


Baran J, Bojarsky M, Halada S, Ricarte-Filho JC, Isaza A, Franco AT, Surrey LF, Bhatti T, Baloch ZW, Adzick NS, Mostoufi-Moab S, Kazahaya K, Bauer A. Low-Invasive Somatic Oncogenes and Lymph Node Metastasis in Pediatric Papillary Thyroid Cancer: Implications for Prophylactic Central Neck Dissection , Eur Thyroid J, 13: 2024,e230265


Tondi Resta I, Rind A, Montone KT, Livolsi VA, Baloch ZW. A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions , Hum Pathol, 149: 2024,29-38


Arisi MF, Jin X, Ravish NA, Chand MT, Baloch Z. How important are the cytomorphologic subtypes of the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan system for reporting salivary gland cytology? An institutional experience 2018-2024 , Diagn Cytopathol: 2024


Williams MD, Liu Z, Rossi ED, Agarwal S, Ryška A, Ghuzlan AA, Bychkov A, Baloch Z, Chernock R, Chiosea SL, Cipriani NA, Erkilic S, Fridman M, Hang JF, Harahap AS, Jung CK, Kakudo K, Khalil M, Khanafshar E, Kumarasinghe P, Lloyd R, Nguyen TP, Ocal IT, Prasad ML, Pusztaszeri M, Rana C, Sadow P, Sajed DP, Seethala R, Tallini G, Vuong HG, Yegen G, LiVolsi VA, Nikiforov YE. Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents , J Clin Endocrinol Metab, 110: 2024,166-175


Torous VF, Jitpasutham T, Baloch Z, Cantley RL, Kerr DA, Liu X, Maleki Z, Merkin R, Nosé V, Pantanowitz L, Resta IT, Rossi ED, Faquin WC. Cytologic features of differentiated high-grade thyroid carcinoma: A multi-institutional study of 40 cases , Cancer Cytopathol: 2024


View all publications